Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
23%
OVERLAP
BY WEIGHT
5
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
8%
ALSO IN OZEM
OZEM
19
HOLDINGS
28%
ALSO IN XLV
SECTOR DRIFT (XLV minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.6% | 18.4% | 14.6% |
|
AMGEN INC | 3.1% | 3.5% | 3.1% |
|
PFIZER INC | 2.6% | 3.6% | 2.6% |
|
GILEAD SCIENCES INC | 2.7% | 1.7% | 1.7% |
|
REGENERON PHARMACEUTICALS | 1.4% | 3.3% | 1.4% |
XLV Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 9.1% |
|
ABBVIE INC | 7.1% |
|
UNITEDHEALTH GROUP INC | 5.5% |
|
MERCK & CO. INC. | 4.5% |
|
ABBOTT LABORATORIES | 3.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
INTUITIVE SURGICAL INC | 3.5% |
|
DANAHER CORP | 2.6% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
 |
MEDTRONIC PLC | 2.3% |
XLV Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -14.2% |
|
VIKING THERAPEUTICS, INC. | -5.8% |
 |
ROCHE HOLDING LTD | -5.4% |
|
ZEALAND PHARMA A/S | -5.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.1% |
|
ELI LILLY & CO | -3.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.6% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
 |
HANMI PHARM CO LTD | -3.1% |
|
SCHOLAR ROCK HOLDING CORP. | -3.0% |